Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria
NCT ID: NCT04264312
Last Updated: 2020-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
76220 participants
OBSERVATIONAL
2017-07-28
2020-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
NCT04301908
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
NCT06779864
The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia
NCT05357183
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residents with medical insurance coverage lived in Beijing more than 6 months .
Exclusion Criteria
* Pregnant women;
* Persons with ascites;
* The one whose wound was not cured at the right upper abdomen
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wu Jiang
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wu Jiang
Director of institue for immunization and prevention of Beijing CDC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jiang Wu
Role: STUDY_DIRECTOR
Beijing Center for Disease Prevention and Control
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xicheng District Center for Disease Prevention and Control
Beijing, Beijing Municipality, China
Huairou District Center for Disease Prevention and Control
Beijing, Beijing Municipality, China
Daxing District Center for Disease Prevention and Control
Beijing, Beijing Municipality, China
Chaoyang District Center for Disease Control and Prevention
Beijing, Beijing Municipality, China
Dongcheng District Center for Disease Control and Prevention
Beijing, Beijing Municipality, China
Fengtai District Center for Disease Control and Prevention
Beijing, Beijing Municipality, China
Changping District Center for Disease Prevention and Control
Beijing, , China
FangShan District Center for Disease Prevention and Control
Beijing, , China
Haidian District Center for Disease Prevention and Control
Beijing, , China
Miyun District Center for Disease Prevention and Control
Beijing, , China
Tongzhou District Center for Disease Prevention and Control
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BJCDCWJ202001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.